The gliopeptide ODN, a ligand for the benzodiazepine site of GABAA receptors, boosts functional recovery after stroke
Rhita Lamtahri, Mahmoud Hazime, Emma K. Gowing, Raghavendra Yelahanka Nagaraja, Julie Maucotel, Michael Alasoadura, Pascale Quilichini, Katia Lehongre, Benjamin Lefranc, Katarzyna Gach, Ann-Britt Marcher, Susanne Mandrup, David Vaudry, Andrew N. Clarkson, Jérôme Leprince, Julien Chuquet
This paper shows that the gliopeptide ODN, when administered after day 3 post-stroke, improves motor recovery in mice by correcting cortical excitability.
Journal of Neuroscience · Jul 1, 2021Peer-reviewedNeuroscience